Doença renal do diabetes
Abstract
A doença renal do diabetes (DRD) é a principal causa de ingresso em terapia renal substitutiva e está associada ao aumento de morbidade e mortalidade.Em 2007, o Kidney Disease Outcomes Quality Initiative (KDOQI) propôs usar a expressão doença renal do diabetes no lugar de nefropatia diabética (ND) para ampliar o espectro das formas de doença renal no DM, acrescentando o fenótipo não albuminúrico ao já descrito fenótipo albuminúrico. Tem sido sugerido o uso do termo ND para o quadro específico de albuminúria elevada seguida da perda de função renal.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.